GSK - ENTERED INTO SECONDARY BLOCK TRADE AGREEMENT WITH BOFA SECURITIES UNDER WHICH BOFA SECURITIES APPOINTED AS SOLE GLOBAL COORDINATOR OF OFFERING . | May 11, 2023
GSK plc: GSK ANNOUNCES INTENTION TO SELL SHARES IN HALEON ANNOUNCES THAT IT INTENDS TO SELL UP TO 240M ORDINARY
SHARES IN
HALEON, EQUIVALENT TO UP TO 2.5% OF HALEON S. | May 11, 2023
British drugmaker GSK announced its intention to sell up to 240 million shares in Haleon on Thursday, which represents 2.5% of the consumer healthcare group s issued share capital.. | May 11, 2023
By Michael Susin GSK said Thursday that it will sell its stake in Haleon via a placing to institutional investors. The pharmaceutical major said it intends to sell up to 240 million. | May 11, 2023